109 results
Page 2 of 6
FWP
bxwt7cu7zy 0lv6m34mb
15 Jun 23
Free writing prospectus
7:03am
8-K
EX-99.1
1tih irbu7v
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
EX-99.3
kuplz 5swnkp
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
rbtlnz0cl fqrfn147
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
EX-99.2
1sgdaaubvk0bqboe2c
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
6zz2ee o387
26 May 23
Regulation FD Disclosure
12:38pm
8-K
EX-99.1
tof94t
26 May 23
Regulation FD Disclosure
12:38pm
8-K
EX-99.1
cdbjp q6q8kv154
10 May 23
Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
7:04am
8-K
vt7lc930
26 Apr 23
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
vovfiywh7b2ofqvsy0
26 Apr 23
Regulation FD Disclosure
5:00pm
PRE 14A
zo7jde3
18 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.2
2079iaobq
17 Apr 23
Zentalis announces preclinical data supporting Cyclin E1 as a predictive marker for azenosertib treatment at AACR Annual Meeting 2023
9:07am
8-K
1iphb 593
17 Apr 23
Zentalis announces preclinical data supporting Cyclin E1 as a predictive marker for azenosertib treatment at AACR Annual Meeting 2023
9:07am
8-K
EX-99.1
0ymf1qp 21
17 Apr 23
Zentalis announces preclinical data supporting Cyclin E1 as a predictive marker for azenosertib treatment at AACR Annual Meeting 2023
9:07am